BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
B&K Securities re-initiates Alembic Pharmaceuticals with buy
Stock offers good upside despite high valuation. Expect EBITDA margins to increase further. Domestic business has seen a strategic shift.